Please login to the form below

Not currently logged in
Email:
Password:

licensing agreements

This page shows the latest licensing agreements news and features for those working in and with pharma, biotech and healthcare.

Merck’s COVID-19 antiviral under review in Europe by EMA

Merck’s COVID-19 antiviral under review in Europe by EMA

The company has entered into similar agreements with governments worldwide, including the UK government, which announced last week that it had ordered 480, 000 courses of the antiviral in addition to ... It has previously announced non-exclusive

Latest news

More from news
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    Internal teams led the clinical side of R&D, while business development teams worked to identify collaboration opportunities, including partnerships or licence agreements with other companies to build their pipelines. ... They also can help identify

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    Beyond this network, in the developing world, we have entered into non-exclusive voluntary licensing agreements with nine generic manufacturers to further expand access and supply of remdesivir. ... These agreements are royalty-free during the pandemic

  • Leo has its eyes on the prize Leo has its eyes on the prize

    We will be very active in building partnerships and licensing agreements.

  • A new route to market A new route to market

    Licensing agreements. A common model for many small to medium sized biotech companies taking a first step in exporting is to license a product or technology to a local market partner - ... Licensing agreements are rarely straightforward, and a level of

  • Pharma deals during October 2013 Pharma deals during October 2013

    Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... Pre-existing out-licensing agreements, which include milestones and royalties, remain in effect and these have been transferred into a holding company 75 per cent

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....